DC Chemicals

All products / DC20118

GZD856
CAT. NO. DC20118

GZD856

Pack sizes and prices

Pack sizePrice
100 mg$800 USDRequest a quote / confirm availability →
250 mg$1,450 USDRequest a quote / confirm availability →
1 g$2,800 USDRequest a quote / confirm availability →

Confirm stock, lead time, shipping and final quotation with our team.

Product overview

GZD856 is a novel and orally bioavailable PDGFRα/β inhibitor with IC50s of 68.6 and 136.6 nM, respectively. Anti-lung cancer activities. Also a Bcr-AblT315I inhibitor with IC50s of 19.9 and 15.4 nM for Bcr-Abl and T315I mutant.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC20118
Product nameGZD856
CAS1257628-64-0
Molecular formulaC29H27F3N6O
Molecular weight532.559496164322
Purity>98%
SMILESCc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2ccnn2c1

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — GZD856 (DC20118)

Related research products

Browse newly added products